Chinese herbal medicines for hypertriglyceridaemia - Test2 - elhamkhani - TriplyDB

Chinese herbal medicines for hypertriglyceridaemia

Chinese herbal medicines for hypertriglyceridaemia

http://www.wikidata.org/entity/Q24202020

about

Supplementation with the extract of schisandrae fructus pulp, seed, or their combination influences the metabolism of lipids and glucose in mice fed with normal and hypercholesterolemic diet Efficacy of Chinese herbal medicine for stroke modifiable risk factors: a systematic review.

P2860

Q33614303-1E052A9C-68C9-4765-993C-A266101B3C63 Q41613442-31DB611B-F960-48BD-9C43-AF2523225B27

P2860

Chinese herbal medicines for hypertriglyceridaemia

http://www.wikidata.org/entity/Q24202020

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Chinese herbal medicines for hypertriglyceridaemia

@ast

Chinese herbal medicines for hypertriglyceridaemia

@en

Chinese herbal medicines for hypertriglyceridaemia

@en-gb

Chinese herbal medicines for hypertriglyceridaemia

@nl

type

label

Chinese herbal medicines for hypertriglyceridaemia

@ast

Chinese herbal medicines for hypertriglyceridaemia

@en

Chinese herbal medicines for hypertriglyceridaemia

@en-gb

Chinese herbal medicines for hypertriglyceridaemia

@nl

prefLabel

Chinese herbal medicines for hypertriglyceridaemia

@ast

Chinese herbal medicines for hypertriglyceridaemia

@en

Chinese herbal medicines for hypertriglyceridaemia

@en-gb

Chinese herbal medicines for hypertriglyceridaemia

@nl

P1433

Q24202020-B88AFCB9-4B60-4D41-B72C-45ED1F798791

P1476

Q24202020-EAAB0BC2-E20D-48AD-8B6D-B0DC852C3990

P2093

Q24202020-4DF749BB-BAD6-41D7-9855-9F4086ED5883

Q24202020-B0387DD1-34EB-424D-8B6E-150B0A3C5E99

Q24202020-E83BDB65-4713-46C2-BD58-8A17ED1DD6DF

P2860

Q24202020-14BBA39B-95F4-4083-A178-8912FB8FFB91

Q24202020-1B95F4AB-4F5F-4446-B362-DCDF0B91EA88

Q24202020-1C8B6FED-6283-4EAE-9DCA-5E36E121E307

Q24202020-1D20C6E7-4289-49A3-95F0-D01467BADE52

Q24202020-1F72EBE8-CD63-4CB2-9250-2F3C08FA5DA1

Q24202020-2E0ABC9B-9850-4490-BA0D-5F130E880DDB

Q24202020-332F2D9A-013F-40CA-AAE3-1918F21907DA

Q24202020-3A2A3A07-FE33-4CAB-86CE-ED3E5473C0C2

Q24202020-672FC6BA-9B12-42DE-9682-EDF9E3F0887F

Q24202020-6EAEF11F-6776-4FC2-A825-BB8795BE62E2

P304

Q24202020-DFEDD7F3-B235-4AB3-8371-9A0ED217D1CB

P31

Q24202020-1A56636D-81D4-42AD-8DEF-00619B638599

P356

Q24202020-669A3154-67DB-48A4-9CA4-C57CCD92B384

P433

Q24202020-CCB7ABAA-63FE-445D-867C-EAFCAF06A1E4

P50

Q24202020-5BB199B2-C96F-4180-A526-31152AF24174

Q24202020-95728D82-8D54-4076-AC60-295CD53A6003

Q24202020-957950F0-8EDC-4EEB-986E-D752CCD57259

P577

Q24202020-B94298E3-F045-4E6F-952C-B42A965E5E30

P698

Q24202020-6702C318-0A0C-466D-9846-28F69F58E52A

P356

14651858.CD009560.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Chinese herbal medicines for hypertriglyceridaemia

@en

P2093

Jian Ping Liu

http://www.w3.org/2001/XMLSchema#string

Kelvin Chan

http://www.w3.org/2001/XMLSchema#string

Zhao Lan Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Adverse effects of statins - mechanisms and consequences.

The role of hypertriglyceridemia in atherosclerosis.

Myopathy with statin-fibrate combination therapy: clinical considerations.

P304

CD009560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD009560.PUB2

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P50

Alan Bensoussan

P577

2013-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23744539

http://www.w3.org/2001/XMLSchema#string